• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions

    7/1/26 8:00:00 AM ET
    $CI
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email

    New program introduces AI-enabled capabilities to personalize support, streamline prescription processing, and help patients start and stay on therapy with greater ease and confidence

    BLOOMFIELD, Conn., July 1, 2026 /PRNewswire/ -- As specialty care becomes more complex, patients need faster, more connected, and personalized support. To help meet that need, Evernorth, the health services division of The Cigna Group (NYSE:CI), today unveiled Pharmacy Forward, a new AI-powered program designed to improve how patients access and experience specialty care. Launching first with Accredo Specialty Pharmacy – which serves patients with chronic and complex specialty conditions through condition-specific Therapeutic Resource Centers (TRCs) – the program is supported by a $100 million investment through 2028. This investment enables care teams to focus more on clinical care and patient outcomes while reducing prescription processing timelines and improving service responsiveness.

    Evernorth Health Services (PRNewsfoto/Evernorth Health Services)

    "Patients navigating complex health conditions need comprehensive, expert support, often during some of the most difficult moments in their lives," said Matt Perlberg, President of the Evernorth Health Services pharmacy and care delivery businesses, including Accredo, and Executive Vice President of Customer Innovation for The Cigna Group.  "Pharmacy Forward reflects our commitment to meet patients where they are —delivering an even faster, more seamless experience while ensuring they receive the personalized support and clinical care they deserve."

    A Smarter, Faster, More Personalized Specialty Pharmacy Experience

    Pharmacy Forward applies AI across four core areas: clinical care, prescription intake, administration, and medication fulfillment:

    1. Care Enablement — Supporting More Coordinated, Insight-Driven Care: Pharmacy Forward is expected to improve medication adherence beyond the industry standard of 80%, helping patients stay on therapy and achieve optimal health outcomes. By integrating clinical data and insights, AI-generated summaries, and predictive analytics, care teams can deliver more connected, informed support. This enables clinicians to proactively identify patients at risk of falling off therapy or experiencing adverse events, empowering earlier intervention, stronger coordination, and an improved patient experience. The program uses AI to free up more time for clinicians to focus on patient care and is expected to reduce clinician documentation time by up to 50%.



    2. Experience Accelerators – Improving the Patient Journey in Real Time: Pharmacy Forward uses AI-enabled tools to reach patients earlier in their care journey and deliver more proactive, personalized support. For example, Accredo has implemented AI-enabled scheduling so outreach occurs during patients' preferred call windows. Additionally, Accredo anticipates a 25% increase in use of personalized patient digital pathways, enabling more patients to complete routine steps on their own terms — getting answers faster, starting prescriptions through the app or website, and scheduling therapy more easily.



    3. Rx Readiness — Accelerating Time to Therapy: Pharmacy Forward is cutting the time it takes for patients to receive their medication after Accredo receives a prescription in half — helping patients start treatment sooner. By using AI to improve the completeness of prior authorization submissions, identify copay assistance eligibility, and ensure prescriptions are ready earlier in the process, the program is designed to streamline the time it takes to process a prescription and reduce delays in care.



    4. One Fulfillment Network — Delivering Medications Faster and More Reliably: Pharmacy Forward will enhance Accredo's ability to ship complex specialty medications from sites as close to a patient's home as possible, ensuring that 90% of patients are within a 1-day or same day ground shipping radius. To enable this, Accredo is expanding capacity, staffing, and capabilities at many of its nearly 40 care facilities to reduce the need for longer ground or air shipments, which are more susceptible to delays from adverse events such as weather. The enhancements will be supported by AI technology, for example, to continuously analyze factors such as patient location, delivery timing, and medication handling requirements to determine the most effective dispensing location.

    Together, these capabilities represent the next evolution of specialty pharmacy — combining AI, clinical expertise, and operational scale to create a more connected and responsive care experience. The program is expected to generate approximately $400 million in value by the end of 2028, helping make care more coordinated and personalized for the more than one million patients Accredo serves each year. Evernorth expects to extend many of these capabilities to its other pharmacies' operations in the coming years.

    "AI is enabling us to fundamentally reimagine how we support each patient's journey," said Katya Andresen, Chief Data, Digital and AI Officer, The Cigna Group. "By responsibly combining real-time data, advanced analytics and deep clinical expertise, we can deliver more personalized, proactive support — helping people access the care they need faster and achieve better health outcomes."

    About Evernorth Health Services

    Evernorth Health Services is the pharmacy, care, and benefits solutions division of The Cigna Group (NYSE:CI). We create and deliver innovative, flexible, and people-first solutions that solve the most complex health care challenges. Evernorth is home to pioneering brands including Express Scripts, Express Scripts Pharmacy, Accredo, eviCore, and MD Live. We have more than 40,000 employees who work to make health care more affordable, predictable, and simple for the 190 million people we serve. Learn more at evernorth.com.

    Media Contact

    Justine Sessions

    Justine.sessions@evernorth.com

    860-810-6523 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evernorth-launches-pharmacy-forward-a-simpler-faster-specialty-pharmacy-experience-for-patients-managing-complex-conditions-302815277.html

    SOURCE Evernorth

    Get the next $CI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI

    DatePrice TargetRatingAnalyst
    5/26/2026$304.00Overweight → Equal Weight
    Barclays
    5/20/2026$302.00Buy → Hold
    Deutsche Bank
    3/12/2026$358.00Mkt Perform → Outperform
    Bernstein
    10/14/2025$370.00Buy
    Goldman
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    6/26/2024$400.00Overweight
    Piper Sandler
    5/30/2024$388.00Outperform
    Robert W. Baird
    3/6/2024$393.00Overweight
    Barclays
    More analyst ratings

    $CI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Holgerson Bryan claimed ownership of 7,693 shares (SEC Form 3)

    3 - Cigna Group (0001739940) (Issuer)

    7/9/26 7:36:18 PM ET
    $CI
    Medical Specialities
    Health Care

    New insider Kautzner Adam claimed ownership of 13,533 shares (SEC Form 3)

    3 - Cigna Group (0001739940) (Issuer)

    7/9/26 7:34:58 PM ET
    $CI
    Medical Specialities
    Health Care

    New insider Sadler Jason D claimed ownership of 34,705 shares (SEC Form 3)

    3 - Cigna Group (0001739940) (Issuer)

    7/9/26 7:33:43 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Cordani David bought $999,916 worth of shares (4,134 units at $241.88) (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    11/3/25 2:47:56 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Cigna Group's Second Quarter 2026 Earnings Release Details

    BLOOMFIELD, Conn., July 7, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2026 financial results on Thursday, July 30, 2026, and will host a conference call the same day. Second quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:             Live Call             (888) 566-1889 (Domestic)             (773) 799-3989 (International)             Passcode: 07302026             Replay             (866) 405-7290 (Domestic) 

    7/7/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions

    New program introduces AI-enabled capabilities to personalize support, streamline prescription processing, and help patients start and stay on therapy with greater ease and confidenceBLOOMFIELD, Conn., July 1, 2026 /PRNewswire/ -- As specialty care becomes more complex, patients need faster, more connected, and personalized support. To help meet that need, Evernorth, the health services division of The Cigna Group (NYSE:CI), today unveiled Pharmacy Forward, a new AI-powered program designed to improve how patients access and experience specialty care. Launching first with Accredo Specialty Pharmacy – which serves patients with chronic and complex specialty conditions through condition-specif

    7/1/26 8:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Foundation Honors David M. Cordani's Leadership with New Grant to Strengthen Military Communities

    New "Courage in Service" grant builds on company's long-standing support for military and veteran communities.BLOOMFIELD, Conn., June 25, 2026 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE:CI), today announced the launch of the David M. Cordani Courage in Service Grant, a new $1.5 million, 10-year commitment to support the health and well-being of military and veteran communities by prioritizing social connection. The grant comes as Cordani, who has served as chief executive officer of The Cigna Group for 17 years, is set to retire as

    6/25/26 10:14:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Cigna Group downgraded by Barclays with a new price target

    Barclays downgraded The Cigna Group from Overweight to Equal Weight and set a new price target of $304.00

    5/26/26 8:44:05 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded The Cigna Group from Buy to Hold and set a new price target of $302.00

    5/20/26 8:05:39 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group upgraded by Bernstein with a new price target

    Bernstein upgraded The Cigna Group from Mkt Perform to Outperform and set a new price target of $358.00

    3/12/26 8:38:26 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    SEC Filings

    View All

    SEC Form 11-K filed by The Cigna Group

    11-K - Cigna Group (0001739940) (Filer)

    6/24/26 4:27:09 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Cigna Group (0001739940) (Filer)

    5/13/26 6:01:44 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    5/12/26 4:18:20 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Leadership Updates

    Live Leadership Updates

    View All

    The Cigna Group Foundation Honors David M. Cordani's Leadership with New Grant to Strengthen Military Communities

    New "Courage in Service" grant builds on company's long-standing support for military and veteran communities.BLOOMFIELD, Conn., June 25, 2026 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE:CI), today announced the launch of the David M. Cordani Courage in Service Grant, a new $1.5 million, 10-year commitment to support the health and well-being of military and veteran communities by prioritizing social connection. The grant comes as Cordani, who has served as chief executive officer of The Cigna Group for 17 years, is set to retire as

    6/25/26 10:14:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director

    HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company" or "KYN") announced today the appointment of Michael J. Hennigan as an independent director of the Company, effective immediately. Following the retirements of William R. Cordes and Barry R. Pearl earlier this year, the appointment of Mr. Hennigan brings the Company's Board to six members, five of whom are independent. Michael J. Hennigan is a highly accomplished energy executive, with several decades of leadership experience in the refining and midstream sectors. Mr. Hennigan most recently served as Executive Chairman of Marathon Petroleum Corporation (NYSE:MPC) and MPLX LP (NYSE:MPLX

    5/12/26 4:20:00 PM ET
    $CI
    $KYN
    $MPC
    Medical Specialities
    Health Care
    Finance/Investors Services
    Finance

    The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer

    Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group Board of DirectorsEvanko elected to the company's Board of DirectorsCompany reaffirms 2026 Financial OutlookBLOOMFIELD, Conn., March 3, 2026 /PRNewswire/ -- The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive officer effective July 1, 2026, and become executive chair of The Cigna Group's Board of Directors. Brian Evanko, current president and chief operating officer, will succeed Cordani as CEO. Throughout his tenure—inclu

    3/3/26 7:30:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Financials

    Live finance-specific insights

    View All

    The Cigna Group's Second Quarter 2026 Earnings Release Details

    BLOOMFIELD, Conn., July 7, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2026 financial results on Thursday, July 30, 2026, and will host a conference call the same day. Second quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:             Live Call             (888) 566-1889 (Domestic)             (773) 799-3989 (International)             Passcode: 07302026             Replay             (866) 405-7290 (Domestic) 

    7/7/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook

    Total revenues for the first quarter 2026 increased 5% to $68.5 billionShareholders' net income for the first quarter 2026 was $1.7 billion, or $6.26 per shareAdjusted income from operations1 for the first quarter 2026 was $2.1 billion, or $7.79 per share2026 outlook2 for adjusted income from operations1,2 increased to at least $30.35 per share2BLOOMFIELD, Conn., April 30, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported first quarter 2026 results, reflecting growth across its diversified portfolio of businesses."We continue to improve how people experience health care, leveraging innovation and technology to make it more personalized, more transparent and

    4/30/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Declares Quarterly Dividend

    BLOOMFIELD, Conn., April 22, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.56 per share of its common stock, payable on June 18, 2026, to shareholders of record as of the close of business on June 4, 2026. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services mar

    4/22/26 4:30:00 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by The Cigna Group

    SC 13G - Cigna Group (0001739940) (Subject)

    11/12/24 9:55:14 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/13/24 5:02:29 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/9/24 8:50:20 AM ET
    $CI
    Medical Specialities
    Health Care